Wordt geladen...
Idiopathic Thrombocytopenic Purpura: A Rare Syndrome with Alemtuzumab, Review of Monitoring Protocol
Alemtuzumab, a humanized monoclonal antibody that targets surface molecule CD52, causes rapid and complete depletion of circulating T- and B-lymphocytes through antibody-dependent cell-mediated and complement-mediated cytotoxicity. Alemtuzumab has demonstrated superior efficacy compared to subcutane...
Bewaard in:
| Gepubliceerd in: | Cureus |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Cureus
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823085/ https://ncbi.nlm.nih.gov/pubmed/31720183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5715 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|